Clinical study to evaluate the effectiveness and safety of eggshell powder to improve skin health (skin photo-aging and skin moisturizing)
- Conditions
- Not Applicable
- Registration Number
- KCT0009068
- Lead Sponsor
- mariedm
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 100
1) Men and women aged 25 to 60 with 3 grade to 7 grade in wrinkles and skin color around the eyes and 49 A.U. or less in the cheek area
2) A healthy person with no acute, chronic physical illness, including skin disease
3) A person who voluntarily prepared and signed a consent form to participate in the clinical trial after hearing sufficient explanation from the researcher about the purpose, content, possible adverse reactions, etc. of the study
4) A person who can follow up during the study period
1) A person who has a skin disease or has a specific allergic reaction to a raw material similar to a clinical trial product
2) A person who has used oral and skin external preparations containing steroids or retinoids within 24 weeks of screening
3) A person who participated in a similar clinical trial and the same study within 24 weeks of screening
4) A person with skin abnormalities such as spots, acne, erythema, capillary dilatation, etc. on the test site
5) A person who has used cosmetics or medicines of the same or similar ingredients on the test site within 12 weeks of screening
6) Those who have taken medicines and herbal medicines that can affect test results within 12 weeks of screening (hormone preparations, oral contraceptives, diuretics, acne treatments, hair loss drugs, Allergic rhinitis medications (Fexo-genadine components such as alicresin and allegra) and ACE inhibitor (angiotensin converting enzyme inhibitor) among high blood pressure drugs
7) A person who has continuously consumed health functional foods and general foods that may affect the test results within 12 weeks of screening (this test material and
Health functional foods or general foods containing similar ingredients, protein-containing foods, collagen-containing products, hyaluronic acid, biotin, beer yeast, skin lactic acid bacteria, aloe gel, konjac potato extract, pomegranate-containing products, Vitamin C, ceramide, gamma-linolenic acid, amphitheater, N-acetylglucosamine, noni fruit, chlorella, Spirulina, etc.)
8) A person who has undergone procedures (skin ablation, Botox, laser, other skincare, etc.) on the test site within 24 weeks of screening
9) A person who plans to become pregnant, is pregnant, or is breastfeeding within 24 weeks of screening
10) Those who have experienced drug-sensitive (hyperactive) or allergic reactions
11) People with uncontrolled hypertension or diabetes (excluding those who take drugs with NO synthetic metastasis among high blood pressure drugs)
12) Those with clinically significant diseases (cardiovascular, dyslipidemia, endocrine, digestive, urinary diseases, neuropsychiatric diseases, malignancies) that require treatment (however, after the operation
Participation is possible if it has not recurred for more than 5 years)
13) Those whose diagnostic test results are deemed inappropriate during screening visits (ALT (GOT), those whose AST (GPT) is more than three times the upper limit of the reference range, and those whose serum creatine is 2.0 mg/dl or more)
14) A smoker or a person who has quit smoking for less than one year
15) Other persons deemed difficult to participate in the examination due to the judgment of the research manager
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method crow’s feet;skin elasticity;skin moisturizing
- Secondary Outcome Measures
Name Time Method crow’s feet (Visual evaluation);Distance and density of the dermis layer;Transepidermal water loss;Amount of dead skin cells;Skin roughness;serum MMP-2, MMP-9